December 08, 2022

Red Light Holland’s Todd Shapiro on investing in a medical and scientific division for the understanding of medical psychedelics

“We have named a Science and Innovation division called Scarlette Lillie… We thought that this is a way to show investors how serious we are about our medical, our scientific and research division because not only is Red Light Holland a recreational opportunity, where we plan our products on shelves by Q4, but we also want to show the world that we are taking this side very seriously of trying to prove and being a part of the process of what psilocybin can potentially do for human beings…We want to create this division and grow this division to get involved with observational studies, clinical studies and show the scientific community and be a part of some intellectual property…” States Todd Shapiro, Co-Founder, CEO and Director of Red Light Holland Corp. (CSE: TRIP), in an interview with InvestorIntel’s Tracy Weslosky.

Todd went on to comment on the appointment of Canada’s former Health Minister, the Honourable, Tony P. Clement, as a Senior Advisor to Red Light Holland’s Advisory Board. Mr. Clement has served in senior roles in Prime Minister Stephen Harper’s Cabinet (2006-2015), as Health Minister, Industry Minister and President of the Treasury Board. Todd also said that Red Light Holland has a strong cash position and is building a very strong team which includes Dr. Joseph Geraci, a leading mind in the medicine and machine learning fields and global comedy superstar, Russell Peters.

To access the complete interview, click here

Disclaimer: Red Light Holland Corp. is an advertorial member of InvestorIntel Corp.

Disclaimer: The author of this post may or may not be a shareholder of any of the companies mentioned in this column. None of the companies discussed in the above feature have paid for this content. The writer of this article/post/column/opinion is not an investment advisor, and is neither licensed to nor is making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence. To access the InvestorIntel.com disclaimer and other important legal notices, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *